Key China COVID-19 examination delivered results that affected ensuing exploration on Covid Kumar Jeetendra | September 18, 2020 Crucial China COVID-19 study produced results that Affected subsequent research on coronavirus Early in the start of the COVID-19 pandemic, a small study in China produced results that affected subsequent research on the virus. Researchers at the University of Cincinnati used the same research parameters on a much larger patient population and reached completely different …
Study shows tofacitinib medication can fix porousness absconds in the digestive tract Kumar Jeetendra | October 6, 2020 A team of researchers led by biomedical scientist Declan F. McCole in the University of California, Riverside, has found that the medication tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can fix permeability defects in the intestine. Study results appear in the Journal of Crohn’s and Colitis. …
Female mosquitoes can distinguish a mix of four unique substances in blood Kumar Jeetendra | October 13, 2020 Mosquitoes spread diseases like malaria, dengue, and yellow fever that kill at least a half a million people each year. Researchers are learning what people taste like to mosquitoesdown to the individual neurons that sense blood’s distinctive, flavorful taste. Female mosquitoes have a sense of taste that is especially tuned to detect a combination of …
CBD could lessen lung harm brought about by COVID-19 Kumar Jeetendra | October 19, 2020 One way CBD appears to reduce the”cytokine storm” that damages the lungs and kills many individuals with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is proven to reduce inflammation and whose levels are dramatically reduced in the face of this storm. Dental College of Georgia and Medical …
SARS-CoV-2 hereditary changes may have made COVID-19 more infectious Kumar Jeetendra | October 31, 2020 A study involving over 5,000 COVID-19 patients in Houston finds the virus which causes the disease is accumulating genetic mutations, one of which may have made it longer infectious. According to the paper published in the peer reviewed journal mBIO, that mutation, known as D614G, is found in the spike protein that pries open our …
Engineered counter acting agent may forestall Covid from contaminating human cells Kumar Jeetendra | November 4, 2020 By screening hundreds of artificial antibodies, researchers at Karolinska Institutet in Sweden and EMBL Hamburg in Germany have identified an antibody that may prevent the new coronavirus from infecting human cells. The analysis, which is printed in the journal Nature Communications, also reveals how electrons can be quickly generated in the event of future pandemics. …
Hematoxylin compounds can specifically kill CALR mutant cancer cells Kumar Jeetendra | December 11, 2020 Patients with myeloproliferative neoplasm (MPN), a group of malignant diseases of the bone marrow, often have a carcinogenic mutated form of the calreticulin gene (CALR). Researchers of the research team of Robert Kralovics, Adjunct Principal Investigator in the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and team leader at the …
Study distinguishes protein as likely restorative objective for leishmaniasis vaccine Kumar Jeetendra | December 12, 2020 According to the results of research led by the Complutense University of Madrid (UCM), among the various strategies deployed by the Leishmania parasite to avoid tripping the human immune system is to trigger the SHP-1 protein. The parasite does this by secreting a molecule capable of interacting with the Mincle receptor expressed by antigen-presenting dendritic …
Researchers grow new serological assay for discovery of SARS-CoV-2 antibodies Kumar Jeetendra | December 13, 2020 Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus which causes COVID-19. Rebecca DuBois, associate professor of biomolecular engineering at UC Santa Cruz, said the new method her staff developed is as accurate as the most dependable antibody tests now available, but is less …
Hematoxylin compounds can specifically kill CALR freak disease cells Kumar Jeetendra | December 20, 2020 Patients with myeloproliferative neoplasm (MPN), a group of malignant diseases of the bone marrow, often have a carcinogenic mutated form of the calreticulin gene (CALR). Scientists of the research group of Robert Kralovics, Adjunct Principal Investigator in the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and team leader at the …
Trinity crew uncovers mutations connected with early onset dementia Kumar Jeetendra | December 22, 2020 Researchers at Trinity College Dublin today announced a significant advance in our knowledge of an early onset form of dementia which may also advance our understanding of conditions such as Alzheimer’s disease. Adult onset Leukoencephalopathy with axonal Spheroids and Pigmented glia (ALSP) is an ultra-rare condition characterized by mutations in a gene named Colony stimulating …
New drug mixture improves blood glucose manipulate and weight reduction in mice Kumar Jeetendra | December 23, 2020 Scientists have demonstrated that adding an experimental cancer drug to a widely used diabetes treatment improves blood glucose control and weight loss in mice, according to a study published today in eLife. The results pave the way for clinical trials of this new drug combination as a more successful long-term remedy for countless individuals with …
